News

Recent Options Activity Insights on Acadia Healthcare Co

Recent Options Activity Insights on Acadia Healthcare Co

Whales and the Options Market for Acadia Healthcare Co

Recently, we have noticed significant bullish sentiment towards Acadia Healthcare Co. This interest by large investors hints at promising expectations for the company's performance in the near future.

An examination of the trading history reveals that Acadia Healthcare Co (ACHC) has experienced ten notable trades. Approximately 40% of these transactions were initiated by investors anticipating bullish outcomes, while 20% were aligned with bearish projections.

Analyzing the overall trades, we witnessed 7 puts valued at $294,214 and 3 calls amounting to $213,245. This distribution indicates a complex view among investors regarding the future direction of Achadia's stock.

Understanding the Price Targets

From reviewing the trading patterns, major investors seem to target a price range between $30.00 and $35.00 for Acadia Healthcare Co within the past quarter. This price goal reflects the cautious optimism many traders harbor for the company's short-term trajectory.

Current Volume and Open Interest Analysis

On this trading day, the average open interest for Acadia Healthcare's options stands at 612, with total trading volume reaching 6,410. This impressive volume showcases heightened activity among traders. An accompanying chart would illustrate the changes in both call and put option volume along with open interest for high-value transactions in the specified price range over the last month.

Significant Options Activity

In recent trades, critical insights emerged that reflect investor sentiment:

  • One noteworthy trade involved calls executed as part of a large sweep, with a neutral sentiment and an expiration date of March 21, 2025, suggesting that investors are trying different strategies to capitalize on price movements.
  • Additionally, other notable trades included calls with bullish sentiments, indicating a variety of investor strategies and expectations.

About Acadia Healthcare Co

Acadia Healthcare Co Inc is focused on creating and enhancing behavioral healthcare facilities across the United States and internationally. Specifically, a considerable portion of Acadia’s earnings comes from acute inpatient psychiatric facilities and specialty treatment centers located in the U.S. These facilities predominantly rely on payments from Medicaid, with substantial revenue also generated from private insurers. In markets like the United Kingdom, Acadia's financial support is primarily from the National Health Service.

This current trading sentiment encourages a dive into Acadia's performance metrics to understand the business’s operations better.

Current Positioning of Acadia Healthcare Co

  • As of today, ACHC is trading with a volume of 3,278,446 shares, reflecting a drop of -23.92%, bringing the stock price down to $30.63.
  • Indicators such as the RSI suggest that the stock may currently be oversold, presenting a potential buying opportunity.
  • The anticipated earnings announcement is expected in roughly two months.

Analyst Ratings on Acadia Healthcare Co

In the last month, analysts have weighed in on ACHC, providing a range of insights and opinions. The average price target currently stands at $39.75. This shows a mixture of optimism and caution among professionals regarding Acadia's growth.

Several analysts’ ratings have shifted, illustrating a diverse range of evaluations:

  • Barclays has adjusted its rating downward to Equal-Weight with a new price target of $35.
  • B of A Securities maintains a Buy rating while setting a price target of $44.

This volatile options trading rate indicates higher risks; however, perceptive traders navigate these challenges by keeping knowledgeable on various strategies. It’s crucial for investors to stay informed regarding Acadia Healthcare Co, especially with ongoing trading activities and future potential.

Frequently Asked Questions

What is Acadia Healthcare Co's main service focus?

Acadia Healthcare Co specializes in acquiring and developing behavioral healthcare facilities in the U.S., U.K., and Puerto Rico.

What recent trading patterns have been observed for Acadia?

Recent patterns show 40% of trades were bullish, while 20% were bearish, indicating mixed investor sentiments.

What is the current stock price of Acadia Healthcare Co?

As of now, Acadia Healthcare Co is trading at approximately $30.63.

How does Acadia's revenue structure work?

Revenue largely comes from Medicaid payments and commercial payors in the U.S., with the U.K. primarily relying on the National Health Service.

What do analysts expect for Acadia's stock?

Analysts project an average price target of $39.75, reflecting a range of opinions on the stock’s future performance.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

U.S. Court Ruling Opens Market for Cocrystal's CrysQnol™

Updated Category News Views 9

Legal Drama Clears Market Path Well, folks, here’s a win from the trenches for Cocrystal Tech that can shake up the nutraceutical market. Kaneka's grip on the patent for their ubiquinol concoctions just got busted by the U.S. District Court. They ruled that Kaneka's claims lacked utility and enablement, essentially saying they were pitching an untested hypothesis as an...

Continue Reading
Chef André Chiang Reimagines A Joy's Autumn Menu

Updated Category News Views 3

The Culinary World of Chef André Chiang There's a brand-new aroma wafting through Taiwan's dining scene, and it's got Chef André Chiang's signature all over it. Partnering with A Joy, a high-end buffet restaurant, this all-star chef is giving us something worth the chatter: an autumn menu that's as much about memories as it is about taste. We're looking at flavors that...

Continue Reading
Thermoplastic Polyimide: A $0.86 Billion Market by 2032

Updated Category News Views 1

It's not often you get hyped about a compound with a name like 'thermoplastic polyimide,' but hold your horses—this isn't just any chemical. If you're watching markets with a sharp eye, you’ll see this thing estimated at $0.56 billion in 2026, gunning for a hefty $0.86 billion by 2032. We're talking about a solid 7.4% CAGR ride here folks, according to new data from...

Continue Reading
WaFd and EverBank $3.9B Deal Spurs Big Bank Shift

Updated Category News Views 0

Remember the good old days when banking was just about collecting interest? Now it's all about combining forces to bolster strength, and that's just what we're seeing with WaFd, Inc. (NASDAQ: WAFD) and EverBank Financial Corp flipping the script and shaking hands on a $3.9 billion reverse merger. Strategic Vision: A New Chapter They're calling it a 'strategic...

Continue Reading
Early Orders Key for Custom Kids' Gifts This Season

Updated Category News Views 2

Unwrap the Secret to Perfect Holiday Presents When it comes to giving the little ones something special for the holidays, the trick lies in timing. Not your run-of-the-mill timing, mind you—I'm talking about understanding how handcrafted, personalized toys can make or break the season. If you've ever scrambled for a last-minute gift, you know how that shaky feeling sets...

Continue Reading
Indiana Fire Safety: The Importance of Regular Inspections

Updated Category News Views 3

Everybody thinks of fire extinguishers as those red cans hanging quietly on walls, but there's more to them than meets the eye. In Central Indiana, these devices are a literal lifeline, and neglecting their upkeep is playing with fire—literally. What Makes Monthly Checks a Big Deal? Fire extinguishers aren't just there for decoration. They're critical safety gear. This...

Continue Reading
Jixingfeng Advances Smart Manufacturing for Socks Market

Updated Category News Views 3

Socks Evolve: From Feet Covers to Tech Gear Once upon a time, socks were merely foot covers, destined to vanish beneath pants and shoes. But not anymore. In the bustling halls of the sock world, Jixingfeng built up a robust repertoire of producing high-performance hosiery for a modern market that demands more than just warmth. They’ve turned socks into a tech-infused...

Continue Reading
Ping An Climbs Sustainability Ladder, Scores A+ Rating

Updated Category News Views 5

Sustainability Triumph for Ping An: A+ Upgrade Ping An Insurance (Group) Company of China, Ltd. is having quite the moment, snagging an A+ in the latest 2026 Sustainability Rating from Hang Seng Indexes Company. This ain't just a one-time pat on the back—it's the third year of consecutive improvement. Looks like Ping An's focus on ESG efforts is finally getting the...

Continue Reading
CME Group Smashes FX Open Interest Record Again

Updated Category News Views 4

Shattering Records: CME Group's Latest Milestone Well, here's a juicy nugget for your investment playbook. On September 4, 2026, CME Group proved, once again, why they're the big dog in the derivatives yard, announcing a new record in FX open interest—4,410,167 contracts! This tops the previous mark of 4,269,622 contracts set just a few months back. The futures and...

Continue Reading
CalExitNow Fights Federal Interference in CA Elections

Updated Category News Views 2

California's Election Integrity: A Ticking Time Bomb Strap in for a bumpy ride, folks—California might soon find its electoral process caught in a Washington whirlwind. CalExitNow, the group advocating for California's independence, is sounding alarms about looming federal interventions that could shake the state's democratic foundations. The Federal Storm Rolling In...

Continue Reading

Top 5 Most Recently Viewed Articles

BPC Instruments Hits the Mark with Repeat Orders in Denmark

Updated Category News Views 196

BPC Instruments Strikes Repeat Orders BPC Instruments AB is at it again—smacking down big news with two repeat orders from Denmark worth about SEK 1.1 million. Now, for those scratching their heads, Denmark is no slouch when it comes to biogas applications, so it’s no surprise these guys are doubling down on their instruments. What’s the Deal? Both orders are coming...

Continue Reading
Ralph Bumbaca Steps Up to Lead TD Bank in Metro New York

Updated Category News Views 157

Ralph Bumbaca Steps Up as Regional President of TD Bank TD Bank has announced that Ralph Bumbaca will serve as the new Regional President for Metro New York. This area encompasses various significant regions, notably New York City, Long Island, Hudson Valley, and parts of Northern New Jersey. Bumbaca will operate from Manhattan, leading a diverse array of commercial and...

Continue Reading
FOXO Technologies Expands Portfolio with Vector Biosource Acquisition

Updated Category News Views 154

FOXO Technologies Welcomes Vector Biosource into Its Family FOXO Technologies Inc. (OTC: FOXO) has taken a significant step forward by signing a stock purchase agreement to acquire Vector Biosource Inc. This acquisition is poised to enhance FOXO's capabilities in biotechnology, clinical research, and pharmaceutical sectors. Vector, a well-established provider of...

Continue Reading
Renew Labs Secures CAP Accreditation, Marks Key Milestone

Updated Category News Views 8

Renew Labs Achieves Prestigious CAP Accreditation Well, here's something that's got my attention today—Renew Labs, the lab arm of Renew Biotechnologies, just bagged accreditation from the College of American Pathologists (CAP). Now, before you roll your eyes thinking this ain't of any significance, let me spell it out. In the lab world, CAP's stamp of approval is like...

Continue Reading
ENERQUALITY Welcomes New Leadership with a Strong Vision

Updated Category News Views 292

ENERQUALITY Unveils New Board of Directors and Leadership In a significant move forward, Brian Johnston, the Interim Chair of ENERQUALITY, has proudly announced the establishment of a fresh Board of Directors. This announcement marks a pivotal moment for the organization, which aims to enhance its position in the realm of high-performance home construction. The New...

Continue Reading